Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_pagePreview
Managing Patient Enrollment in Acromegaly Rare Disease Studies

In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Current Trends in Allergy Immunotherapy

Pharm-Olam is an allergy focused CRO and have worked on over 35 allergy clinical trials. In this article, we explore the area...


(8 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology

Understanding the New Asthma Guidelines

In the midst of the COVID-19 pandemic, breathing issues and respiratory conditions are significant concerns. According to the ...


(4 minute read)

Tags: Pharm-Olam Insights, Allergy & Immunology, Asthma

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover